Sanofi reaches deal on terms of sale of consumer health arm, say …
13 hours ago · PARIS (Reuters) -Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R), French ...
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella
3 hours ago · Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at around 16 billion euros ($17 billion), or 14 times estimated core ...
Sanofi enters exclusive talks with CD&R for Opella sale
3 hours ago · The French pharmceutical company said its Opella business has been valued at around 16 billion euros ($17.38 billion), or 14 times EBITDA in 2024, and French public investment bank Bpifrance is ...
Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
2 hours ago · Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at $17.4 billion, including debt.
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions …
3 hours ago · Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a ...
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI | Reuters
13 hours ago · France will take a stake in Sanofi 's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro newspaper that U.S ...
Sanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella …
1 hour ago · Headquartered in France, Opella employs over 11,000 people and operates in 100 countries, supported by 13 strategic manufacturing sites and four science and innovation development centers.
Sanofi 'surprised' by PAI Partners' raised bid for Opella unit
3 days ago · PARIS, Oct 17 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Thursday it was "surprised" by a renewed, higher offer for its consumer arm Opella from private equity firm PAI ...
Paris backs €15B sale of paracetamol-maker to US fund
12 hours ago · Policy news; Events; News; Trade; Paris backs €15B sale of paracetamol-maker to US fund after winning guarantees ... Bpifrance, the country’s public investment bank, will take shares in Opella, the Sanofi subsidiary that is being sold to the American fund, but will not have a controlling majority.
PAI Partners makes higher offer for Sanofi's Opella, source says
PARIS (Reuters) -A consortium led by French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, a source close to the matter said on ...
- Some results have been removed